• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌中雄激素受体基因3'非编码区的基因序列变化。

A genetic sequence change in the 3'-noncoding region of the androgen receptor gene in prostate carcinoma.

作者信息

Paz A, Lindner A, Zisman A, Siegel Y

机构信息

Urology Department, Assaf Harofeh Medical Center, Zerifin, Israel.

出版信息

Eur Urol. 1997;31(2):209-15. doi: 10.1159/000474452.

DOI:10.1159/000474452
PMID:9076468
Abstract

OBJECTIVE

We intended to identify structural changes in the hormone-binding domain and C-terminal region of the androgen receptor (AR) gene in carcinoma of prostate specimens.

METHODS

Twelve prostate cancer specimens from prostate resections were analyzed for the presence of mutations in the E-H exons and part of the 3'-untranslated region of the AR cDNA, using RT-PCR and direct sequencing.

RESULTS

A polymorphic sequence spanning 17 nucleotides was identified in the 3'-untranslated region of the AR cDNA from one prostate carcinoma tissue, suggesting the presence of a somatic mutation. No mutations were identified in the coding sequence of the hormone-binding domain of the AR cDNA.

CONCLUSION

These results suggest that AR mutations are probably uncommon molecular events in the early stages of prostate cancer.

摘要

目的

我们旨在鉴定前列腺癌标本中雄激素受体(AR)基因的激素结合域和C端区域的结构变化。

方法

使用逆转录聚合酶链反应(RT-PCR)和直接测序法,对12例前列腺切除术后的前列腺癌标本进行分析,以检测AR cDNA的E-H外显子和部分3'-非翻译区中是否存在突变。

结果

在一个前列腺癌组织的AR cDNA的3'-非翻译区中鉴定出一个跨越17个核苷酸的多态性序列,提示存在体细胞突变。在AR cDNA激素结合域的编码序列中未鉴定出突变。

结论

这些结果表明,AR突变可能是前列腺癌早期阶段不常见的分子事件。

相似文献

1
A genetic sequence change in the 3'-noncoding region of the androgen receptor gene in prostate carcinoma.前列腺癌中雄激素受体基因3'非编码区的基因序列变化。
Eur Urol. 1997;31(2):209-15. doi: 10.1159/000474452.
2
Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.雄激素非依赖性前列腺癌中的雄激素受体突变:癌症与白血病B组研究9663
J Clin Oncol. 2003 Jul 15;21(14):2673-8. doi: 10.1200/JCO.2003.11.102.
3
Mutation screening of the androgen receptor promoter and untranslated regions in prostate cancer.前列腺癌中雄激素受体启动子及非翻译区的突变筛查
Prostate. 2006 Nov 1;66(15):1585-91. doi: 10.1002/pros.20387.
4
Androgen receptor mutations in high-grade prostate cancer before hormonal therapy.激素治疗前高级别前列腺癌中的雄激素受体突变
Lab Invest. 2003 Dec;83(12):1709-13. doi: 10.1097/01.lab.0000107262.40402.44.
5
Expression and somatic mutation on androgen receptor gene in prostate cancer.前列腺癌中雄激素受体基因的表达与体细胞突变
Int J Urol. 2002 Oct;9(10):545-53. doi: 10.1046/j.1442-2042.2002.00514.x.
6
Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen-mediated up-regulation of AR messenger RNA.雄激素受体(AR)编码区域中的多个雄激素反应元件和一个Myc共有序列位点参与雄激素介导的AR信使核糖核酸的上调。
Mol Endocrinol. 1999 Nov;13(11):1896-911. doi: 10.1210/mend.13.11.0369.
7
p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.原发性前列腺癌中的p53异常:与基因组DNA相比,互补DNA的单链构象多态性分析。前列腺癌协作网络。
J Natl Cancer Inst. 1997 Jan 1;89(1):66-71. doi: 10.1093/jnci/89.1.66.
8
Microsatellite mutation (CAG24-->18) in the androgen receptor gene in human prostate cancer.人类前列腺癌雄激素受体基因中的微卫星突变(CAG24→18)
Biochem Biophys Res Commun. 1994 Jan 14;198(1):74-80. doi: 10.1006/bbrc.1994.1011.
9
p53 tumour suppressor gene mutations in benign prostatic hyperplasia and prostate cancer.良性前列腺增生和前列腺癌中的p53肿瘤抑制基因突变
Eur Urol. 1998;34(5):433-40. doi: 10.1159/000019778.
10
Androgen receptor gene mutations in hormone-refractory prostate cancer.激素难治性前列腺癌中的雄激素受体基因突变
J Pathol. 1999 Dec;189(4):559-63. doi: 10.1002/(SICI)1096-9896(199912)189:4<559::AID-PATH471>3.0.CO;2-Y.